UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043297
Receipt number R000049411
Scientific Title Cancer morbidity in patients with cardiac dysfunction with left ventricular ejection fraction <50%
Date of disclosure of the study information 2021/02/10
Last modified on 2022/08/13 17:34:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Cancer morbidity in patients with cardiac dysfunction with left ventricular ejection fraction <50%

Acronym

Cancer morbidity in patients with cardiac dysfunction

Scientific Title

Cancer morbidity in patients with cardiac dysfunction with left ventricular ejection fraction <50%

Scientific Title:Acronym

Cancer morbidity in patients with cardiac dysfunction

Region

Japan


Condition

Condition

heart failure

Classification by specialty

Cardiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To identify the cancer morbidity of patients with cardiac dysfunction

Basic objectives2

Others

Basic objectives -Others

Descriptive study

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Cancer morbidity of patients with cardiac dysfunction

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with echocardiographic evidence of left ventricular ejection fraction of 50% or less

Key exclusion criteria

None

Target sample size

3000


Research contact person

Name of lead principal investigator

1st name Shinya
Middle name
Last name Fujiki

Organization

Niigata University Graduate School of Medical and Dental Sciences

Division name

Department of Cardiovascular Biology and Medicine

Zip code

951-8510

Address

1-757 Asahimachidori, Chuo-ku, Niigata

TEL

025-227-2185

Email

sfujiki@med.niigata-u.ac.jp


Public contact

Name of contact person

1st name Shinya
Middle name
Last name Fujiki

Organization

Niigata University Graduate School of Medical and Dental Sciences

Division name

Department of Cardiovascular Biology and Medicine

Zip code

951-8510

Address

1-757 Asahimachidori, Chuo-ku, Niigata

TEL

025-227-2185

Homepage URL


Email

sfujiki@med.niigata-u.ac.jp


Sponsor or person

Institute

Niigata University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The ethical committees of Niigata University

Address

1-757 Asahimachidori, Chuo-ku, Niigata

Tel

025-227-2625

Email

ethics@adm.niigata-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 02 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2019 Year 06 Month 20 Day

Date of IRB

2019 Year 07 Month 22 Day

Anticipated trial start date

2019 Year 08 Month 01 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry

2022 Year 10 Month 31 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information

1. Gender, age, past history, comorbidities, medication
2. Date of onset, type of cancer
3. Height, weight, vital signs
4. Blood test
5. 12 Lead ECG
6. Echocardiography


Management information

Registered date

2021 Year 02 Month 10 Day

Last modified on

2022 Year 08 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049411


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name